Reshape Biotech Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
56
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$20M
- Investors
-
16
Reshape Biotech General Information
Description
Developer of AI and robotics-powered imaging and analysis platform designed to automate data-driven experimentation. The company's platform combines flexible robotics and machine learning and offers technology that is developed in a way that every machine performs a different task in the labs and does not create an overload on any single multitasking robot, enabling researchers and engineers to have access to automation alternatives that permit them to spend their time efficiently.
Contact Information
Website
www.reshapebiotech.comCorporate Office
- Østbanegade 55
- 1st floor
- 2100 Copenhagen
- Denmark
Corporate Office
- Østbanegade 55
- 1st floor
- 2100 Copenhagen
- Denmark
Reshape Biotech Timeline
Reshape Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 09-Apr-2024 | $20M | Completed | Generating Revenue | ||
| 6. Seed Round | 09-Feb-2023 | Completed | Generating Revenue | |||
| 5. Seed Round | 27-May-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 3. Angel (individual) | Completed | Startup | ||||
| 2. Grant | 01-Oct-2020 | $126K | $21.1K | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2019 | $21.1K | $21.1K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Reshape Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Reshape Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Reshape Biotech Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 21st.Bio | Corporation | Minority | ||
| Astanor Ventures | Impact Investing | Minority | ||
| Angel (individual) | Minority | |||
| R7 | Venture Capital | Minority | ||
| ACME Capital | Venture Capital | Minority |
Reshape Biotech FAQs
-
When was Reshape Biotech founded?
Reshape Biotech was founded in 2018.
-
Where is Reshape Biotech headquartered?
Reshape Biotech is headquartered in Copenhagen, Denmark.
-
What is the size of Reshape Biotech?
Reshape Biotech has 56 total employees.
-
What industry is Reshape Biotech in?
Reshape Biotech’s primary industry is Electronic Equipment and Instruments.
-
Is Reshape Biotech a private or public company?
Reshape Biotech is a Private company.
-
What is Reshape Biotech’s current revenue?
The current revenue for Reshape Biotech is .
-
How much funding has Reshape Biotech raised over time?
Reshape Biotech has raised $29.2M.
-
Who are Reshape Biotech’s investors?
21st.Bio, Astanor Ventures, , R7, and ACME Capital are 5 of 16 investors who have invested in Reshape Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
